Back to search
FDAFDA · Food and drugs·Recall number Z-1742-2019

MRSASelect, IVD, REF 63747, containing 20 plates per package. The MRSASelect is indicated for use in conjunction with other laboratory tests and clinical data available to aid in the identification and diagnosis of MRSA from patients with skin and soft-tissue infections.

Published June 12, 2019 · Recall initiated: June 8, 2018

Summary

FDA records medical device Class II recall Z-1742-2019, published June 12, 2019 and initiated June 8, 2018. Recalling firm: Bio-Rad Laboratories, Inc; Status: Terminated; Reported quantity: 5,212 units; Lot: Lot numbers 64179161, exp. 6/8/2018; 64180987, exp. 6/15/2018; 64182474, exp. 6/23/2018; 64184888, exp. 6/30/2018; 64187551, exp. 7/6/2018; 64189117, exp. 7/13/2018; 64190797, exp. 7/22/2018; and 64192125, exp. 8/3/2018. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Abnormal coloration of agar plates and the growth of non-characteristic MRSA colonies.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Bio-Rad Laboratories, Inc
Distributor
US Nationwide Distribution to: AK, AL, AR, AZ, CA, CO, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, WA, WI, WV, WY, and Puerto Rico.
Lot
Lot numbers 64179161, exp. 6/8/2018; 64180987, exp. 6/15/2018; 64182474, exp. 6/23/2018; 64184888, exp. 6/30/2018; 64187551, exp. 7/6/2018; 64189117, exp. 7/13/2018; 64190797, exp. 7/22/2018; and 64192125, exp. 8/3/2018.
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was MRSASelect, IVD, REF 63747, containing 20 plates per package. The MRSASelect is indicated for use in conjunction with other laboratory tests and clinical data available to aid in the identification and diagnosis of MRSA from patients with skin and soft-tissue infections. recalled?

Yes. FDA published recall Z-1742-2019 on June 12, 2019. Reported hazard: Abnormal coloration of agar plates and the growth of non-characteristic MRSA colonies.

What should I do if I have this product?

Voluntary: Firm initiated · Letter